ATE177747T1 - Spiro(heterozyclische-imidazo(1,2-a>indeno(1,2- e>pyrazin>-4'-one, ihre herstellung und diese enthaltende arzneimittel - Google Patents

Spiro(heterozyclische-imidazo(1,2-a>indeno(1,2- e>pyrazin>-4'-one, ihre herstellung und diese enthaltende arzneimittel

Info

Publication number: ATE177747T1
Authority: AT; Austria
Prior art keywords: alk; coor6; het; pct; receptor
Prior art date: 1994-11-02

Application number

AT95936624T

Other languages

English (en)

Inventor

Jean-Claude Aloup

Francois Audiau

Michel Barreau

Dominique Damour

Arielle Genevois-Borella

Patrick Jimonet

Serge Mignani

Yves Ribeill

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-11-02

Filing date

1995-10-30

Publication date

1999-04-15

1995-10-30 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

1999-04-15 Application granted granted Critical

1999-04-15 Publication of ATE177747T1 publication Critical patent/ATE177747T1/de

Links

KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 title 2
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1
UUDAMDVQRQNNHZ-UHFFFAOYSA-N (S)-AMPA Chemical compound CC=1ONC(=O)C=1CC(N)C(O)=O UUDAMDVQRQNNHZ-UHFFFAOYSA-N 0.000 abstract 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
239000002464 receptor antagonist Substances 0.000 abstract 2
229940044551 receptor antagonist Drugs 0.000 abstract 2
FUFZNHHSSMCXCZ-UHFFFAOYSA-N 5-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole Chemical group FC(F)(F)C1=CC=CC(C=2N=C(ON=2)C2CCNCC2)=C1 FUFZNHHSSMCXCZ-UHFFFAOYSA-N 0.000 abstract 1
102000003678 AMPA Receptors Human genes 0.000 abstract 1
108090000078 AMPA Receptors Proteins 0.000 abstract 1
239000004471 Glycine Substances 0.000 abstract 1
102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 abstract 1
108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical group C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
239000003446 ligand Substances 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
230000036963 noncompetitive effect Effects 0.000 abstract 1
ORTFAQDWJHRMNX-UHFFFAOYSA-M oxidooxomethyl Chemical compound [O-][C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-M 0.000 abstract 1
230000000144 pharmacologic effect Effects 0.000 abstract 1
102000005962 receptors Human genes 0.000 abstract 1
108020003175 receptors Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/20—Spiro-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

AT95936624T 1994-11-02 1995-10-30 Spiro(heterozyclische-imidazo(1,2-a>indeno(1,2- e>pyrazin>-4'-one, ihre herstellung und diese enthaltende arzneimittel ATE177747T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9413060A FR2726275B1 (fr)	1994-11-02	1994-11-02	Spiro heterocycle-imidazo(1,2-a)indeno(1,2-e)pyrazine)-4'- ones, leur preparation et les medicaments les contenants

Publications (1)

Publication Number	Publication Date
ATE177747T1 true ATE177747T1 (de)	1999-04-15

Family

ID=9468413

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95936624T ATE177747T1 (de)	1994-11-02	1995-10-30	Spiro(heterozyclische-imidazo(1,2-a>indeno(1,2- e>pyrazin>-4'-one, ihre herstellung und diese enthaltende arzneimittel

Country Status (12)

Country	Link
US (1)	US5777114A (de)
EP (1)	EP0789699B1 (de)
JP (1)	JPH10508311A (de)
AT (1)	ATE177747T1 (de)
AU (1)	AU3848595A (de)
DE (1)	DE69508421T2 (de)
DK (1)	DK0789699T3 (de)
ES (1)	ES2130669T3 (de)
FR (1)	FR2726275B1 (de)
GR (1)	GR3029714T3 (de)
WO (1)	WO1996014318A1 (de)
ZA (1)	ZA959044B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005506292A (ja) *	2001-03-08	2005-03-03	エモリー　ユニバーシティ	ｐＨに依存するＮＭＤＡレセプターアンタゴニスト
US7045527B2 (en)	2002-09-24	2006-05-16	Amgen Inc.	Piperidine derivatives
US7732162B2 (en)	2003-05-05	2010-06-08	Probiodrug Ag	Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
CA2667839C (en) *	2006-10-30	2016-01-12	Hybrigenics Sa	Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
US8278345B2 (en)	2006-11-09	2012-10-02	Probiodrug Ag	Inhibitors of glutaminyl cyclase
US9126987B2 (en)	2006-11-30	2015-09-08	Probiodrug Ag	Inhibitors of glutaminyl cyclase
JP5930573B2 (ja)	2007-03-01	2016-06-15	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤の新規使用
JP5667440B2 (ja)	2007-04-18	2015-02-12	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
EA201070077A1 (ru) *	2007-06-29	2010-08-30	Эмори Юниверсити	Антагонисты nmda-рецепторов с нейропротективным действием
PL2475428T3 (pl)	2009-09-11	2015-12-31	Probiodrug Ag	Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
EP2338492A1 (de)	2009-12-24	2011-06-29	Universidad del Pais Vasco	Verfahren und Zusammensetzung zur Behandlung von Alzheimer
EP2542549B1 (de)	2010-03-03	2016-05-11	Probiodrug AG	Glutaminylcyclase-hemmer
US8269019B2 (en)	2010-03-10	2012-09-18	Probiodrug Ag	Inhibitors
US8541596B2 (en)	2010-04-21	2013-09-24	Probiodrug Ag	Inhibitors
US8530670B2 (en)	2011-03-16	2013-09-10	Probiodrug Ag	Inhibitors
ES2812698T3 (es)	2017-09-29	2021-03-18	Probiodrug Ag	Inhibidores de glutaminil ciclasa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4354027A (en) *	1980-05-19	1982-10-12	Usv Pharmaceutical Corporation	Triazoloquinoxalin-4-ones
DK101290D0 (da) *	1990-04-24	1990-04-24	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
FR2696466B1 (fr) *	1992-10-02	1994-11-25	Rhone Poulenc Rorer Sa	Dérivés de 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant.
FR2707643B1 (fr) *	1993-07-16	1995-08-11	Rhone Poulenc Rorer Sa	Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant.

1994
- 1994-11-02 FR FR9413060A patent/FR2726275B1/fr not_active Expired - Fee Related
1995
- 1995-10-25 ZA ZA959044A patent/ZA959044B/xx unknown
- 1995-10-30 AU AU38485/95A patent/AU3848595A/en not_active Abandoned
- 1995-10-30 ES ES95936624T patent/ES2130669T3/es not_active Expired - Lifetime
- 1995-10-30 JP JP8515088A patent/JPH10508311A/ja not_active Ceased
- 1995-10-30 US US08/836,410 patent/US5777114A/en not_active Expired - Fee Related
- 1995-10-30 DK DK95936624T patent/DK0789699T3/da active
- 1995-10-30 EP EP95936624A patent/EP0789699B1/de not_active Expired - Lifetime
- 1995-10-30 DE DE69508421T patent/DE69508421T2/de not_active Expired - Fee Related
- 1995-10-30 WO PCT/FR1995/001430 patent/WO1996014318A1/fr not_active Ceased
- 1995-10-30 AT AT95936624T patent/ATE177747T1/de not_active IP Right Cessation
1999
- 1999-03-18 GR GR990400113T patent/GR3029714T3/el unknown

Also Published As

Publication number	Publication date
ES2130669T3 (es)	1999-07-01
FR2726275A1 (fr)	1996-05-03
ZA959044B (en)	1996-05-22
EP0789699A1 (de)	1997-08-20
AU3848595A (en)	1996-05-31
FR2726275B1 (fr)	1996-12-06
GR3029714T3 (en)	1999-06-30
WO1996014318A1 (fr)	1996-05-17
JPH10508311A (ja)	1998-08-18
EP0789699B1 (de)	1999-03-17
US5777114A (en)	1998-07-07
DK0789699T3 (da)	1999-10-11
DE69508421D1 (de)	1999-04-22
DE69508421T2 (de)	1999-07-15

Similar Documents

Publication	Publication Date	Title
ATE177747T1 (de)	1999-04-15	Spiro(heterozyclische-imidazo(1,2-a>indeno(1,2- e>pyrazin>-4'-one, ihre herstellung und diese enthaltende arzneimittel
AU5687496A (en)	1996-10-30	New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
AR006119A1 (es)	1999-08-11	Compuestos de quinoxalinadionas uso de los mismos para la fabricacion de un medicamento, compuestos de quinoxalinas para producirlos y procedimiento parala preparacion de los mismos
NO308075B1 (no)	2000-07-17	5H-indeno[1,2-b]pyrazin-2,3-dionderivater, samt medikamenter inneholdende forbindelsene
ES2158099T3 (es)	2001-09-01	Derivados de imidazo(1,2-a)indeno(1,2-e)pirazina-4-ona y composiciones farmaceuticas que los contienen.
DE69509888D1 (de)	1999-07-01	IMIDAZO[1,2-a]INDENO [1,2-e] PYRAZINONE ANTAGONISTEN DER AMPA UND NMDA REZEPTOREN
FR2358406A1 (fr)	1978-02-10	Derives d'acides 5-aroyl-1,2-dihydro-3h-pyrrolo (1,2-a)pyrrole-1-carboxyliques, leur obtention et leur application a titre de medicament
DE69409796D1 (de)	1998-05-28	Neue verwendung bis-heterocyclische verbindungen und dessen zusammensetzungen
EP1081136A4 (de)	2002-07-03	Optisch aktive tetrahydrobenzindol-derivate
ATE18226T1 (de)	1986-03-15	Pyrrolo(2,3-d)carbazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ATE42292T1 (de)	1989-05-15	Imidazo(1,2-c)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
IL97913A0 (en)	1992-06-21	Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
DE69512419D1 (de)	1999-10-28	IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-2-CARBONSÄURE DERIVATE, IHRE HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL
ATE86993T1 (de)	1993-04-15	Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
DE3887102D1 (de)	1994-02-24	Substituierte Derivate von 20,21-Dinoreburnamenin, Verfahren zur Herstellung und so hergestellte Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammenstellungen.
ATE42291T1 (de)	1989-05-15	Spiro(indolo(1,7-ab>(1,5>benzodiazepin-2,4'piperidine> und zwischenprodukte, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
MX9303392A (es)	1994-06-30	Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
FI955141A0 (fi)	1995-10-27	Pyrido(1,2,3-de)kinoksaliinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeissä
MX9707528A (es)	1997-11-29	Derivados de 5h,10h-imidazo[1,2-a]indeno[1,2-e]pirazin-4-ona, su preparacion y los medicamentos que los contienen.
ES464773A1 (es)	1978-09-01	Procedimiento para la preparacion de 2,9-dioxatriciclo (4,3,1,03,7)decanos.
ATE109485T1 (de)	1994-08-15	Derivate von n-(vincristinyl-23) und n- (noranhydro-5-vinblastinyl-23) von amino-1- methylphosphonsäure, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE112268T1 (de)	1994-10-15	2-amino-1,2,3,4-tetrahydroisochinolin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE67206T1 (de)	1991-09-15	6h-isoxazolo(3,4-d>pyrazolo(3,4-b>pyridine, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.

Legal Events

Date	Code	Title
1999-10-15	UEP	Publication of translation of european patent specification
2005-03-15	EEFA	Change of the company name
2009-07-15	REN	Ceased due to non-payment of the annual fee